GSC
NVO

Grey Street Capital’s Novo Nordisk NVO Stock Holding History

Grey Street Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.71M Buy
36,403
+18,641
+105% +$2.22M 0.64% 25
2023
Q4 		$1.84M Buy
+17,762
New +$1.76M 0.88% 30

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Grey Street Capital's NVO Position: Q1 2024 in Review

Grey Street Capital increased its Novo Nordisk (NVO) stake by 105% in Q1 2024, buying an estimated $2.22M and bringing the position to 36,403 shares worth $4.71M. The position accounts for 0.64% of the portfolio, ranked #25.

Grey Street Capital first reported a position in NVO in Q4 2023 and has held it in 2 quarters since. 1,746 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

  • Grey Street Capital held 36,403 shares of Novo Nordisk worth $4.71M as of Q1 2024.
  • Grey Street Capital bought 18,641 Novo Nordisk shares in Q1 2024, an estimated $2.22M.
  • Novo Nordisk made up 0.64% of Grey Street Capital's portfolio in Q1 2024, its #25 holding.
  • Grey Street Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 2 quarters since.
  • 1,746 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on Grey Street Capital's 13F filing for Q1 2024, filed 9 Aug 2024.